30 employees
ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets
2021
$67M
from 1 investors over 1 rounds
Ensem Therapeutics raised $67M on April 6, 2022
Investors: GGV Capital